Literature DB >> 10049263

Cloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IV.

T Akasaka1, Y Onodera, M Tanaka, K Sato.   

Abstract

The topoisomerase IV subunit A gene, parC homolog, has been cloned and sequenced from Pseudomonas aeruginosa PAO1, with cDNA encoding the N-terminal region of Escherichia coli parC used as a probe. The homolog and its upstream gene were presumed to be parC and parE through sequence homology with the parC and parE genes of other organisms. The deduced amino acid sequence of ParC and ParE showed 33 and 32% identity with that of the P. aeruginosa DNA gyrase subunits, GyrA and GyrB, respectively, and 69 and 75% identity with that of E. coli ParC and ParE, respectively. The putative ParC and ParE proteins were overexpressed and separately purified by use of a fusion system with a maltose-binding protein, and their enzymatic properties were examined. The reconstituted enzyme had ATP-dependent decatenation activity, which is the main catalytic activity of bacterial topoisomerase IV, and relaxing activities but had no supercoiling activity. So, the cloned genes were identified as P. aeruginosa topoisomerase IV genes. The inhibitory effects of quinolones on the activities of topoisomerase IV and DNA gyrase were compared. The 50% inhibitory concentrations of quinolones for the decatenation activity of topoisomerase IV were from five to eight times higher than those for the supercoiling activities of P. aeruginosa DNA gyrase. These results confirmed that topoisomerase IV is less sensitive to fluoroquinolones than is DNA gyrase and may be a secondary target of new quinolones in wild-type P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049263      PMCID: PMC89156     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  47 in total

1.  New topoisomerase essential for chromosome segregation in E. coli.

Authors:  J Kato; Y Nishimura; R Imamura; H Niki; S Hiraga; H Suzuki
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

Review 2.  Bacterial diversity based on type II DNA topoisomerase genes.

Authors:  W M Huang
Journal:  Annu Rev Genet       Date:  1996       Impact factor: 16.830

3.  Mapping the active site tyrosine of Escherichia coli DNA gyrase.

Authors:  D S Horowitz; J C Wang
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

4.  Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant.

Authors:  Y Inoue; K Sato; T Fujii; K Hirai; M Inoue; S Iyobe; S Mitsuhashi
Journal:  J Bacteriol       Date:  1987-05       Impact factor: 3.490

5.  Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase.

Authors:  S L Swanberg; J C Wang
Journal:  J Mol Biol       Date:  1987-10-20       Impact factor: 5.469

6.  DNA sequence of the E. coli gyrB gene: application of a new sequencing strategy.

Authors:  T Adachi; M Mizuuchi; E A Robinson; E Appella; M H O'Dea; M Gellert; K Mizuuchi
Journal:  Nucleic Acids Res       Date:  1987-01-26       Impact factor: 16.971

7.  Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases.

Authors:  T Akasaka; S Kurosaka; Y Uchida; M Tanaka; K Sato; I Hayakawa
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

8.  Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa.

Authors:  B L Masecar; R A Celesk; N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

9.  Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.

Authors:  H Yoshida; M Nakamura; M Bogaki; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

10.  Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.

Authors:  H Yoshida; M Bogaki; M Nakamura; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

View more
  5 in total

1.  Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.

Authors:  T Akasaka; M Tanaka; A Yamaguchi; K Sato
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis.

Authors:  L M Weigel; G J Anderson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

3.  Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone.

Authors:  Didier Hocquet; Xavier Bertrand; Thilo Köhler; Daniel Talon; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa.

Authors:  Melissa Agnello; Annie Wong-Beringer
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

5.  The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.

Authors:  Roghayeh Nouri; Mohammad Ahangarzadeh Rezaee; Alka Hasani; Mohammad Aghazadeh; Mohammad Asgharzadeh
Journal:  Braz J Microbiol       Date:  2016-07-26       Impact factor: 2.476

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.